Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.31
Delayed Data
As of Apr 24
 -0.05 / -2.12%
Today’s Change
2.00
Today|||52-Week Range
7.15
-3.75%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.36
Today’s open2.40
Day’s range2.29 - 2.41
Volume83,769
Average volume (3 months)133,223
Market cap$30.6M
Data as of 4:00pm ET, 04/24/2018

Growth & Valuation

Earnings growth (last year)+66.73%
Earnings growth (this year)--
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+3.70%
P/E ratioNM
Price/Sales0.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc+0.04+0.46%
CDMOPAvid Bioservices Inc-0.20-0.79%
TCONTRACON Pharmaceutica...0.000.00%
AMPEAmpio Pharmaceutical...-0.12-3.97%
Data as of 6:30pm ET, 04/24/2018

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$146.1M
Annual profit (last year)-$77.1M
Net profit margin-52.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Senior VP, Chief Financial &
Business Officer
Angus Smith
Corporate headquarters
Morristown, New Jersey

Forecasts